Gastroenterology
Volume 135, Issue 4 , Pages 1200-1206 , October 2008

Primary Biliary Cirrhosis Is Associated With a Genetic Variant in the 3′ Flanking Region of the CTLA4 Gene

  • Brian D. Juran

      Affiliations

    • Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota
    • ,
  • Elizabeth J. Atkinson

      Affiliations

    • Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota
    • ,
  • Erik M. Schlicht

      Affiliations

    • Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota
    • ,
  • Brooke L. Fridley

      Affiliations

    • Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minnesota
    • ,
  • Konstantinos N. Lazaridis

      Affiliations

    • Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota
    • Corresponding Author InformationAddress requests for reprints to: Konstantinos N. Lazaridis, MD, CBRDD, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota 55905. fax: (507) 284-0762

Received 29 February 2008 ,Accepted 19 June 2008.

References 

  1. Selmi C, Invernizzi P, Zuin M, et al. Genes and (auto)immunity in primary biliary cirrhosis. Genes Immun. 2005;6:543–556
  2. Invernizzi P, Selmi C, Mackay IR, et al. From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2005;3:401–410
  3. Lazaridis KN, Juran BD. American Gastroenterological Association future trends committee report: the application of genomic and proteomic technologies to digestive disease diagnosis and treatment and their likely impact on gastroenterology clinical practice. Gastroenterology. 2005;129:1720–1752
  4. Gregersen PK, Behrens TW. Genetics of autoimmune diseases–disorders of immune homeostasis. Nat Rev Genet. 2006;7:917–928
  5. Goodnow CC, Sprent J, Fazekas de St. Groth B, et al. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature. 2005;435:590–597
  6. Walunas TL, Lenschow DJ, Bakker CY, et al. CTLA-4 can function as a negative regulator of T-cell activation. Immunity. 1994;1:405–413
  7. Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T-cell activation. J Exp Med. 1996;183:2541–2550
  8. Brunner MC, Chambers CA, Chan FK, et al. CTLA-4-mediated inhibition of early events of T cell proliferation. J Immunol. 1999;162:5813–5820
  9. Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 1995;270:985–988
  10. Tivol EA, Borriello F, Schweitzer AN, et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995;3:541–547
  11. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases—a general susceptibility gene to autoimmunity?. Genes Immun. 2000;1:170–184
  12. Maurer M, Loserth S, Kolb-Maurer A, et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics. 2002;54:1–8
  13. Anjos S, Nguyen A, Ounissi-Benkalha H, et al. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem. 2002;277:46478–46486
  14. Ligers A, Teleshova N, Masterman T, et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2001;2:145–152
  15. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423:506–511
  16. Graham DS, Wong AK, McHugh NJ, et al. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Hum Mol Genet. 2006;15:3195–3205
  17. Malquori L, Carsetti L, Ruberti G. The 3'-UTR of the human CTLA4 mRNA can regulate mRNA stability and translational efficiency. Biochim Biophys Acta. 2008;1779:60–65
  18. Oaks MK, Hallett KM. Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol. 2000;164:5015–5018
  19. Oaks MK, Hallett KM, Penwell RT, et al. A native soluble form of CTLA-4. Cell Immunol. 2000;201:144–153
  20. Maier LM, Anderson DE, De Jager PL, et al. Allelic variant in CTLA4 alters T-cell phosphorylation patterns. Proc Natl Acad Sci U S A. 2007;104:18607–18612
  21. Agarwal K, Jones DE, Daly AK, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol. 2000;32:538–541
  22. Fan LY, Zhong RQ, Tu XQ, et al. Genetic association of tumor necrosis factor (TNF)-α polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population. Zhonghua Gan Zang Bing Za Zhi. 2004;12:160–162
  23. Donaldson P, Veeramani S, Baragiotta A, et al. Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2007;5:755–760
  24. Oertelt S, Kenny TP, Selmi C, et al. SNP analysis of genes implicated in T-cell proliferation in primary biliary cirrhosis. Clin Dev Immunol. 2005;12:259–263
  25. Schott E, Witt H, Pascu M, et al. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease. Eur J Gastroenterol Hepatol. 2007;19:947–951
  26. Juran BD, Atkinson EJ, Schlicht EM, et al. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology. 2008;47:563–570
  27. Lazaridis KN, Juran BD, Boe GM, et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology. 2007;46:785–792
  28. Carlson CS, Eberle MA, Rieder MJ, et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004;74:106–120
  29. Anjos SM, Tessier MC, Polychronakos C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J Clin Endocrinol Metab. 2004;89:6257–6265
  30. Limaye N, Belobrajdic KA, Wandstrat AE, et al. Prevalence and evolutionary origins of autoimmune susceptibility alleles in natural mouse populations. Genes Immun. 2008;9:61–68
  31. El-Serag HB, White DL, Mitra N. Genetic association studies: from “searching under the lamppost” to “fishing in the pond”. Gastroenterology. 2008;134:662–664

 Supported by grants from the NIH (K23 DK68290, RO3 DK78527, and RO1 DK80670; to K.N.L.); the American Gastroenterological Association (AGA); the Foundation for Digestive Health and Nutrition (FDHN); the American Liver Foundation; the Palumbo Foundation; the Miles and Shirley Fiterman Foundation; and the Mayo Clinic College of Medicine.

 Conflicts of interest: No conflicts of interest exist.

PII: S0016-5085(08)01146-3

doi: 10.1053/j.gastro.2008.06.077

Gastroenterology
Volume 135, Issue 4 , Pages 1200-1206 , October 2008

Article Tools